Option Care Health (NASDAQ:OPCH) Price Target Raised to $33.00

Option Care Health (NASDAQ:OPCH) had its target price boosted by Barrington Research from $32.00 to $33.00 in a research note released on Tuesday morning,Benzinga reports. The firm currently has an outperform rating on the stock.

Several other brokerages have also recently commented on OPCH. Truist Financial dropped their price target on Option Care Health from $41.00 to $34.00 and set a “buy” rating for the company in a research report on Friday, November 1st. Jefferies Financial Group lowered shares of Option Care Health from a “buy” rating to a “hold” rating and dropped their target price for the stock from $38.00 to $26.00 in a report on Thursday, October 31st. UBS Group began coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a “neutral” rating and a $26.00 price target on the stock. Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and upped their price objective for the company from $26.00 to $33.00 in a research note on Monday. Finally, The Goldman Sachs Group lowered shares of Option Care Health from a “buy” rating to a “neutral” rating and decreased their target price for the stock from $38.00 to $27.00 in a research note on Monday, November 4th. Three investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company. According to data from MarketBeat.com, Option Care Health currently has a consensus rating of “Moderate Buy” and an average target price of $29.86.

Option Care Health Price Performance

NASDAQ:OPCH opened at $28.72 on Tuesday. The stock has a 50 day moving average of $23.33 and a two-hundred day moving average of $27.70. Option Care Health has a 12 month low of $21.39 and a 12 month high of $34.63. The firm has a market cap of $4.89 billion, a P/E ratio of 24.13, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77.

Insider Transactions at Option Care Health

In other Option Care Health news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of the business’s stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the transaction, the director now owns 326,334 shares of the company’s stock, valued at $7,355,568.36. This trade represents a 15.18 % increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.64% of the company’s stock.

Institutional Investors Weigh In On Option Care Health

A number of institutional investors have recently made changes to their positions in OPCH. FMR LLC lifted its holdings in shares of Option Care Health by 134.0% in the 3rd quarter. FMR LLC now owns 7,516,448 shares of the company’s stock worth $235,265,000 after acquiring an additional 4,304,896 shares during the last quarter. Massachusetts Financial Services Co. MA purchased a new stake in Option Care Health in the second quarter valued at approximately $68,003,000. Victory Capital Management Inc. lifted its stake in Option Care Health by 4,432.8% during the third quarter. Victory Capital Management Inc. now owns 1,621,593 shares of the company’s stock worth $50,756,000 after purchasing an additional 1,585,818 shares in the last quarter. Magnetar Financial LLC boosted its position in shares of Option Care Health by 124.8% during the second quarter. Magnetar Financial LLC now owns 2,481,935 shares of the company’s stock worth $68,750,000 after buying an additional 1,377,929 shares during the period. Finally, Wellington Management Group LLP grew its stake in shares of Option Care Health by 15.5% in the third quarter. Wellington Management Group LLP now owns 9,924,915 shares of the company’s stock valued at $310,650,000 after buying an additional 1,328,326 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.